Eli Lilly Japan Helps Students Through Emotional Disorder Educational Programs
This article was originally published in PharmAsia News
Eli Lilly Japan, along with other companies, has helped the Japanese nonprofit organization Association of Corporations and Education develop an educational program on emotional disorders targeting junior high and senior high school students. The development of the program also received advice and input from psychiatrists and patients. Pilot classes of the program were conducted at the end of November. Since then, the program has received accolades from experts in the field. Professor Mizuno of Toho University, a psychiatrist, states that from the point of early discovery and early treatment, teaching the program to junior and high school students who are prone to develop emotional disorders will be useful. The final compilation of materials for the program, including PowerPoint slides, DVD videos, teacher's manuals and videos of pilot classes, is scheduled to be completed by the middle of January. (Click here for more
You may also be interested in...
In the only device-related warning letter released by the US FDA this week, Avazo Healthcare was selling two COVID-19 antigen tests without approval, clearance or authorization from the agency.
A sharp decline in the number of in-person facility inspections has forced the FDA to consider creative techniques for remotely evaluating manufacturer compliance during the COVID-19 pandemic. This and other stories topped our list of most-read Medtech Insight articles in November.
A package of health proposals intended to build up the EU’s resilience to health threats while strengthening the competitiveness of Europe’s pharmaceutical industry and ensuring access to affordable drugs takes a major step through the legislative process this week.